What are drugs like Ozempic doing to the brains of people that binge eat?

Medications like Ozempic are not going anywhere anytime soon.

Twelve percent of US adults have taken a GLP-1 agonist – an increasingly popular type of prescription drug for obesity and diabetes management, that includes popular brands like Ozempic and Mounjaro.

Australia’s Therapeutic Goods Administration recently approved the type 2 diabetes drug tirzepatide (sold as Mounjaro) for use in treating obesity, leading to a nationwide shortage.

Tirzepatide and other GLP-1 agonists mimic hormones that are naturally released after eating, which help to regulate blood sugar and signal fullness to the brain.

While this explains part of their effect, researchers still don’t fully understand how they change...